Literature DB >> 9120727

Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.

K Engels1, S B Fox, R M Whitehouse, K C Gatter, A L Harris.   

Abstract

Angiogenesis, the formation of new blood vessels from the existing vascular network, has been demonstrated to be an important prognostic factor in invasive breast carcinoma. The switch to an angiogenic phenotype represents a growth-limiting step during carcinogenesis and might, in pre-invasive lesions, indicate the risk for developing an invasive phenotype. The discrepancy between modern therapy options for invasive breast carcinomas and the relatively aggressive treatment of in situ lesions underlines the need for such prognostic factors for ductal in situ breast carcinomas (DCIS). Patterns of vascularity were examined in 75 formalin-fixed, paraffin-embedded DCIS by immunohistochemical staining of vessels using antibodies against Factor VIII-related antigen. Histological classification was performed according to four different systems, based on architectural or cytonuclear features, or a combination of both. Two distinct vascular patterns were observed: a diffuse increase of stromal vascularity between duct lesions (pattern I), which was present alone in 8/75 (11 per cent), and a dense rim of microvessels adjacent to the basement membrane of individual ducts (pattern II), present alone in 12/75 (16 per cent). In total, 57 per cent (43/75) showed pattern 1 and 62 per cent (47/75) showed pattern II. There was a significant correlation between these patterns (P = 0.0001; chi 2 = 15.1), such that both were present in 35 (47 per cent). These different vascular patterns imply two angiogenic pathways: one pathway mediated by angiogenic factors released directly by tumour cells resulting in the rim of vessels and another generated indirectly via recruitment of accessory cells such as macrophage and endothelial cells, which themselves release other angiogenic factors, causing the increase of stromal vascularity. A significant increase in both stromal vascularity (pattern I) and the presence of a rim (pattern II) was observed in high-grade DCIS lesions (P = 0.005 and P = 0.037). Indeed, all the patient relapses occurred in these high-grade lesions, but due to the small number of patient events, no significant correlation of vascular pattern to survival was observed (P > 0.05). This study suggests that distinct patterns of vascularity in DCIS might be useful for identifying patients who are at risk of relapse.

Entities:  

Mesh:

Year:  1997        PMID: 9120727     DOI: 10.1002/(SICI)1096-9896(199702)181:2<207::AID-PATH758>3.0.CO;2-4

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  30 in total

1.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Sustained expression of homeobox D10 inhibits angiogenesis.

Authors:  Connie Myers; Aubri Charboneau; Irene Cheung; Douglas Hanks; Nancy Boudreau
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 3.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.

Authors:  A Rice; C M Quinn
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

4.  Breast cancer cell-derived matrix supports vascular morphogenesis.

Authors:  Abigail C Hielscher; Connie Qiu; Sharon Gerecht
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

5.  Tamoxifen Directly Inhibits Platelet Angiogenic Potential and Platelet-Mediated Metastasis.

Authors:  Kelly E Johnson; Jodi A Forward; Mason D Tippy; Julia R Ceglowski; Saleh El-Husayni; Rajesh Kulenthirarajan; Kellie R Machlus; Erica L Mayer; Joseph E Italiano; Elisabeth M Battinelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

6.  Biofunctional characteristics of in situ and invasive breast carcinoma.

Authors:  Sara Bravaccini; Anna Maria Granato; Laura Medri; Flavia Foca; Fabio Falcini; Wainer Zoli; Monica Ricci; Giuseppe Lanzanova; Nestory Masalu; Luigi Serra; Federico Buggi; Secondo Folli; Rosella Silvestrini; Dino Amadori
Journal:  Cell Oncol (Dordr)       Date:  2013-06-27       Impact factor: 6.730

7.  Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis.

Authors:  R Fujiwaki; K Hata; K Iida; Y Maede; M Koike; K Miyazaki
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

8.  Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast.

Authors:  C C Wykoff; N Beasley; P H Watson; L Campo; S K Chia; R English; J Pastorek; W S Sly; P Ratcliffe; A L Harris
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

9.  Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.

Authors:  Mackenzie J Smith; Robert W Berger; Kanwal Minhas; Roger A Moorehead; Brenda L Coomber
Journal:  Int J Exp Pathol       Date:  2010-11-08       Impact factor: 1.925

10.  Definition of the microvascular pattern of the normal human adult mammary gland.

Authors:  Antonio G Naccarato; Paolo Viacava; Guido Bocci; Giovanni Fanelli; Paolo Aretini; Antonino Lonobile; Giancarlo Montruccoli; Generoso Bevilacqua
Journal:  J Anat       Date:  2003-12       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.